Kentucky Biomarker Bill: The Right Test for the Right Treatment

By Cassidy Finley | March 21, 2024

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) The right test for the right treatment.    The Commonwealth of Kentucky enacted HB180 this year which mandates insurance coverage of biomarker testing.  Kentucky joins 13 other states with legislation addressing this complex issue.   Biomarkers can either be direct targets or closely associated indicators of a disease. …

Read More

PGx: Truth, Hope, and Hype

By Cassidy Finley | March 5, 2024

Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) Pharmacogenetics (PGx) is the practice of applying the knowledge of an individual’s genes to guide the best therapeutic options.  Given the generality of this definition, there are numerous ways to implement PGx in practice.  In this article, we’ll cover the basics of PGx, detailing what it is and…

Read More